Hair Loss Platforms That Include Hormone Replacement Therapy (2026)

Detailed Answer

This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any hormone replacement therapy or hair loss treatment.

Reviewed for medical accuracy by the Hormone Journal editorial team. Our editors cross-reference all health claims against peer-reviewed research and clinical guidelines. Last reviewed: March 30, 2026.

Hair loss platforms that include hormone replacement therapy are telemedicine services combining diagnostic hormone testing, targeted hormonal treatment, and hair regrowth medications under unified clinical oversight. Rather than treating hair loss as a cosmetic issue alone, these platforms investigate whether endocrine imbalances — elevated DHT, declining estrogen, or thyroid dysfunction — are driving follicle miniaturization and accelerated shedding.

Most standalone hair loss services prescribe finasteride or minoxidil without checking hormone levels first. That works for many men with straightforward androgenetic alopecia. But for women experiencing diffuse thinning after menopause, men with low testosterone alongside receding hairlines, or anyone with unexplained shedding that does not respond to standard treatment, the hormone piece matters. Research published in the International Journal of Women's Dermatology found that hormonal therapy can manage female pattern hair loss by rebalancing estrogen and progesterone levels, protecting follicles from androgen-driven miniaturization [5]. If you have been tracking your testosterone levels at home and found low readings, that context changes which platform and treatment approach makes sense.

This guide compares six platforms by their hormone testing protocols, treatment options, gender-specific pathways, pricing, and honest limitations.

Platform Comparison at a Glance

Platform	Hormone Testing	HRT Available	Hair Loss Rx	Gender Focus	Region	Monthly Cost
Hims & Hers	Optional (separate program)	Yes (via Hers menopause)	Finasteride, minoxidil	Men + Women (separate)	US	$37-70
Science & Humans	Comprehensive (13+ markers)	Yes (bioidentical)	Finasteride, minoxidil	Men + Women	Canada (8 provinces)	$60-150
MediTresse	Comprehensive (estrogen, progesterone, thyroid)	Yes (bioidentical, anti-androgens)	Minoxidil, spironolactone	Women only	US (major metros)	Case-by-case
Omnia Telehealth	Comprehensive (thyroid, androgens, estrogen)	Yes	Finasteride, minoxidil	Men + Women	US (multi-state)	Varies
Phoenix	Not included	No	Finasteride, minoxidil	Men	Canada	$37-70
Pocketpills	Not included	No	Finasteride, minoxidil	Men + Women	Canada	$37-70

Data sourced from platform websites as of March 2026. "Comprehensive" means the platform runs baseline hormone panels as part of the standard hair loss evaluation. "Optional" means hormone testing is available through a separate program but not integrated into hair loss consultations.

Why Hair Loss and Hormone Therapy Should Be Treated Together

How hormones disrupt the hair growth cycle

Hair follicles cycle through three phases: anagen (active growth, lasting 2 to 7 years), catagen (transition), and telogen (resting, when shedding occurs). Hormones regulate how long each phase lasts and how robustly follicles produce hair.

Dihydrotestosterone (DHT) is the primary hormonal driver of pattern hair loss in both sexes. DHT is a potent androgen converted from testosterone by the enzyme 5-alpha-reductase. It binds to receptors in scalp follicles and causes them to shrink over time — a process called follicle miniaturization, as described in clinical guidance from Vibrant Dermatology [6]. The result is progressively thinner, shorter hairs until the follicle stops producing visible hair altogether.

In women, the picture is more complex. Estrogen has a protective effect against androgens at the follicle level. During perimenopause and menopause, declining estrogen allows the relative androgen balance to shift, and follicles that were previously protected become vulnerable to DHT, according to research in the International Journal of Women's Dermatology [5]. This is why many women notice diffuse thinning over the crown starting in their late 40s or 50s, sometimes alongside other menopause symptoms that worsen despite treatment.

Thyroid dysfunction adds another layer. Both hypothyroidism and hyperthyroidism disrupt metabolic signaling to follicles, causing brittle hair and a condition called telogen effluvium — sudden, widespread shedding that can be alarming but is usually reversible once thyroid levels normalize, as noted by Omnia Telehealth's clinical team [9].

Timeline differences: treating symptoms vs. hormonal root causes

Topical minoxidil alone may reduce shedding within 3 to 6 months by increasing blood flow to follicles, but it does nothing about underlying hormone imbalances, according to Phoenix's clinical overview [8]. If hormonal causes remain untreated, regrowth plateaus and shedding often resumes once treatment stops.

Platforms combining HRT with hair loss medication report that patients typically see stabilization of shedding within 6 months and measurable regrowth by 12 months, as hormone levels normalize and follicles re-enter prolonged anagen phases. According to clinical observations from Oana Health, consistency matters: stopping hormone therapy can reverse progress because the underlying endocrine imbalance persists [1].

For post-menopausal women, estrogen and progesterone supplementation alongside anti-androgen medications like spironolactone has shown the ability to slow follicle miniaturization and improve hair density over 12 to 18 months, according to research published in the International Journal of Women's Dermatology [5].

Gender-specific hormonal pathways in hair loss

Male pattern baldness typically shows up as receding hairlines and crown thinning, driven primarily by DHT sensitivity. According to the American Academy of Dermatology, roughly 50% of men are affected by age 70 [11].

Women produce small amounts of androgens in the ovaries, and when estrogen declines during menopause, the relative androgen excess triggers diffuse thinning rather than the focal recession men experience, as explained by Revitalize You MD [3]. Polycystic ovary syndrome (PCOS) — affecting up to 10% of reproductive-age women according to Mane Advanced Hair's clinical review — elevates androgen levels and can cause both scalp hair loss and excess facial hair simultaneously [2].

Treatment pathways differ accordingly. Men typically receive DHT blockers like finasteride. Women may need estrogen replacement, anti-androgens such as spironolactone, or combination therapy depending on whether hair loss coincides with menopause, PCOS, or thyroid disorders, as outlined by CR Hormone Health [4]. This is why platforms offering gender-specific care pathways tend to produce better outcomes than one-size-fits-all approaches.

Platforms Offering Integrated Hormone Testing and Hair Loss Care

Hims & Hers

Hims & Hers provides telehealth services for hair loss, sexual health, and mental wellness across the United States. The men's program (Hims) offers finasteride starting at $37/month and combination treatments with minoxidil at around $70/month. The women's program (Hers) includes a separate menopause offering with estrogen and progesterone therapy.

The key limitation: these programs are not automatically connected. A patient seeking both hair loss treatment and HRT needs to enroll in two separate programs. Hers does not routinely run DHT or androgen panels as part of hair loss evaluations, so hormonal drivers may go undiagnosed unless the patient specifically requests endocrine testing.

Strengths: Broad US availability, affordable entry pricing, large established user base, fast asynchronous consultations (24-48 hour provider response). Limitations: Hair loss and HRT programs are siloed. No integrated hormone diagnostics for hair patients. Asynchronous model is less suited for complex hormonal cases requiring back-and-forth discussion.

Science & Humans

Science & Humans operates as a Canadian hormone health platform offering testosterone and estrogen replacement therapy alongside hair loss treatment. The platform runs comprehensive hormone panels including testosterone, estrogen, thyroid function (TSH, T3, T4), and DHT levels.

Treatment plans combine bioidentical hormone replacement with finasteride (1 mg) for DHT suppression and topical minoxidil, delivered monthly. Consultation fees start at approximately $100, with monthly medication costs averaging $60 to $90.

Strengths: Deepest diagnostic integration of the Canadian platforms — hormone testing is standard, not optional. Serves both men and women. Video consultations with licensed physicians. Limitations: Canada only (8 provinces). Higher upfront cost than standalone services. Pricing transparency could be clearer — the $100 consultation fee does not always include lab work costs, which vary by province.

MediTresse

MediTresse focuses exclusively on women's hormonal health, offering HRT for menopause, perimenopause, and PCOS alongside hair loss treatment, as detailed in their clinical program overview [2]. The platform runs baseline panels for estrogen, progesterone, testosterone, and thyroid function, then builds personalized plans combining bioidentical hormones, anti-androgens like spironolactone, and topical minoxidil.

Strengths: The most specialized women's hair-hormone platform available. Particular expertise in post-menopausal thinning where estrogen supplementation can restore hair density. Personalized dosing rather than standardized plans. Limitations: Women only — not an option for men. Limited availability outside major US metropolitan areas, where in-person lab partnerships are required for initial testing. Pricing is disclosed case-by-case, which makes comparison shopping harder.

Omnia Telehealth

Omnia Telehealth provides virtual hormone health services with a strong diagnostic focus, according to their clinical program documentation [9]. The platform conducts comprehensive lab panels including thyroid function (TSH, free T3, free T4), androgen profiles (total testosterone, free testosterone, DHT), and estrogen/progesterone levels for women.

Treatment plans may include thyroid medication, testosterone replacement, estrogen therapy, or anti-androgens depending on results, combined with finasteride or minoxidil for hair regrowth.

Strengths: Arguably the most diagnostically rigorous platform reviewed. Providers trained to distinguish between androgenetic alopecia, telogen effluvium, and thyroid-related hair loss. Unlimited follow-up consultations. Limitations: Available in multiple US states but not yet in Canada. Pricing is not published on the website, requiring a consultation before knowing costs.

Phoenix

Phoenix offers online hair loss treatment prescribed by Canadian doctors, with consultations typically approved within 48 hours and medication delivered to the patient's door, according to their service listing [8]. The platform provides finasteride (1 mg), minoxidil topical gel, and combination treatments starting at approximately $37/month.

Strengths: Affordable, fast approval, good option for straightforward male pattern baldness confirmed by a dermatologist. Phoenix reports 90% effectiveness rate based on finasteride clinical data [8]. Limitations: No hormone testing. No HRT. Hair loss treatment only. Not suitable for patients whose thinning may stem from undiagnosed endocrine dysfunction. Men-focused.

Pocketpills

Pocketpills provides Canadian telehealth for hair loss with consultation fees starting at $30 and medication delivery included, according to their treatment page [7]. The platform has delivered over 80,000 hair loss medications.

Strengths: Lowest consultation cost of any reviewed platform. Licensed Canadian physicians prescribe within 48 hours. Good for cost-conscious patients seeking medication access without extensive testing. Limitations: Like Phoenix, no hormone diagnostics and no HRT integration. Patients who suspect hormonal causes would need to coordinate care through separate providers, adding cost and complexity.

How to Choose the Right Platform for Hormonal Hair Loss

When you need integrated care

If hair loss comes alongside other symptoms — fatigue, weight changes, irregular periods, low libido, brain fog — that pattern often points to an underlying endocrine problem rather than standalone androgenetic alopecia, as Omnia Telehealth's clinical team notes [9]. Women in perimenopause or menopause with diffuse thinning benefit most from platforms like MediTresse, Science & Humans, or Omnia Telehealth, where estrogen replacement and anti-androgen therapy address both the hair loss and the systemic hormone decline, according to research in the International Journal of Women's Dermatology [5].

Men with confirmed low testosterone and simultaneous hair recession should look for platforms that combine testosterone replacement with DHT blockers rather than treating hair loss in isolation, according to clinical insights from Oana Health [1]. The rationale: optimizing testosterone while blocking its conversion to DHT can improve both hair density and broader symptoms like low energy and reduced muscle mass.

When standalone treatment is enough

Patients with genetic androgenetic alopecia confirmed by a dermatologist — and no other hormonal symptoms — may find that Phoenix, Pocketpills, or the Hims program provides everything needed. According to Phoenix's clinical data, finasteride alone achieves hair loss stabilization in approximately 90% of men with straightforward pattern baldness [8]. If the only issue is a receding hairline or crown thinning with no signs of systemic hormone imbalance, adding HRT to the treatment plan is unnecessary expense and medication burden.

Cost-conscious patients in Canada who want medication access without extensive testing may prefer Pocketpills' $30 consultation model over the $100+ comprehensive panels that integrated platforms require, as noted on their treatment page [7].

What to Expect: Timelines and Follow-Up

The first 3 to 6 months of combined treatment typically focus on stabilizing shedding as hormone levels normalize and DHT suppression takes effect, according to Oana Health's long-term treatment data [1]. Patients often notice reduced hair fall in the shower and fewer strands on pillows during this window, which indicates follicles are transitioning from telogen back to anagen, as Revitalize You MD explains [3].

Visible regrowth — thicker shafts, increased density — generally appears between 6 and 12 months, though individual timelines vary based on baseline hormone levels, how long the hair loss has progressed, and treatment consistency [1].

Long-term maintenance requires ongoing medication. Stopping finasteride or hormone therapy typically leads to renewed shedding within 6 months as DHT levels rise and hormonal imbalances return, according to Oana Health's clinical observations [1]. Research published by the NIH in the International Journal of Women's Dermatology shows that women on continuous estrogen and anti-androgen therapy maintained improved hair density over 2 to 3 years, while those who discontinued treatment experienced gradual regression [5].

Follow-up schedules differ by platform. Science & Humans schedules quarterly video check-ins with lab monitoring. Omnia Telehealth offers unlimited follow-up consultations. Hims & Hers uses an asynchronous model with provider responses within 24-48 hours. Phoenix and Pocketpills focus primarily on prescription renewals without structured follow-up, according to their respective service pages [7][8].

Costs and Insurance

Monthly costs for combined hair loss and HRT treatment range from $37 to $150, depending on whether the plan includes hormone diagnostics and replacement therapy. Standalone finasteride starts at $37/month across most platforms. Adding minoxidil brings the range to $60-70. Including HRT pushes monthly costs to $100-150, plus potential lab work fees of $200-400 for comprehensive hormone panels.

Canadian provincial health insurance (OHIP, MSP) does not typically cover hair loss medications or HRT prescribed for cosmetic purposes, according to Pocketpills and Phoenix [7][8]. Finasteride is covered in some provinces only when prescribed for benign prostatic hyperplasia, not for hair loss. Private insurance plans vary — some extended health benefits cover 50-80% of HRT and finasteride costs up to an annual maximum, while others exclude hair loss treatments entirely.

In the United States, most insurance plans classify both hair loss and HRT treatments as elective, requiring patients to pay full out-of-pocket costs, as noted by CR Hormone Health and Omnia Telehealth [4][9]. Patients should verify coverage with their specific insurer before enrolling in any telemedicine program.

What Current Research Does Not Show

Hormone replacement therapy for hair loss is a growing field, but several gaps remain in the evidence base. No large-scale randomized controlled trials have directly compared integrated HRT-plus-hair-loss platforms against standalone finasteride treatment for long-term outcomes beyond 3 years. Most clinical data on combined approaches comes from observational studies and individual platform reports rather than independent peer-reviewed research.

For women, the International Journal of Women's Dermatology notes that while estrogen therapy stabilizes follicle miniaturization in 60-70% of post-menopausal cases, the optimal dosing, duration, and combination protocols are still being established [5]. The relationship between thyroid optimization and hair regrowth timelines lacks controlled study data — most evidence is anecdotal or drawn from case reports.

For men, the interaction between testosterone replacement therapy and hair loss is paradoxical: TRT can increase DHT levels and potentially worsen hair loss unless paired with a DHT blocker, but no large trial has established the optimal testosterone-to-finasteride ratio for maximizing both hormonal health and hair density simultaneously.

Patients should treat platform-reported success rates with appropriate skepticism. Claims like "90% effectiveness" typically refer to finasteride monotherapy data from manufacturer-sponsored trials, not to the integrated HRT-plus-hair treatment protocols these platforms offer.

Frequently Asked Questions

What hair loss platforms include hormone replacement therapy?

Telemedicine platforms offering both hormone replacement therapy and hair loss treatment include Science & Humans in Canada, which runs comprehensive hormone panels alongside finasteride and minoxidil prescriptions, and US-based services Omnia Telehealth and MediTresse, which conduct full endocrine evaluations and prescribe estrogen, testosterone, or anti-androgen therapy based on diagnostic results, as documented in their clinical program pages [1][9]. Hims & Hers offers HRT through its separate Hers menopause program but does not integrate hormone diagnostics into standard hair loss consultations.

Can hormone therapy reverse female pattern hair loss?

Hormone therapy can slow progression and improve hair density in women whose pattern hair loss is driven by estrogen decline or androgen excess, but complete reversal is uncommon. Research published in the International Journal of Women's Dermatology indicates that estrogen and anti-androgen therapy stabilizes follicle miniaturization and increases shaft diameter in roughly 60-70% of post-menopausal women, with best results when treatment begins early in the thinning process [5]. Women with advanced follicle atrophy may see limited regrowth even with optimized hormone levels, according to Oana Health's long-term observations [1].

Can low testosterone cause hair loss?

Low testosterone itself does not directly cause hair loss, but it can elevate the ratio of DHT to testosterone, intensifying follicle miniaturization in men genetically predisposed to pattern baldness, as Oana Health's clinical team explains [1]. Platforms that test both total testosterone and DHT levels — such as Science & Humans, Omnia Telehealth, and MediTresse — can determine whether hormone optimization would address hair loss while also improving energy, libido, and muscle mass, according to Vibrant Dermatology's clinical guide [6].

What is the fastest treatment for a receding hairline?

Topical minoxidil combined with oral finasteride is the fastest evidence-based treatment for receding hairlines, with reduced shedding typically noticeable within 3 months and visible regrowth by 6 months, according to Phoenix's clinical data [8]. Clinical evidence suggests 90% of men on finasteride experience hair loss stabilization, while combination therapy increases the likelihood of regrowth at the temples and crown. Addressing underlying hormone imbalances may improve long-term outcomes but typically adds 3-6 months to the timeline as hormone levels normalize, as noted by both Oana Health and Omnia Telehealth [1][9].

Is there a comprehensive treatment for hormonal hair loss?

Comprehensive treatment requires baseline hormone testing (testosterone, estrogen, thyroid, DHT), targeted hormone replacement to correct imbalances, and hair-specific medications to block DHT and stimulate follicle growth, according to Omnia Telehealth's diagnostic protocol [9]. Platforms like Science & Humans, Omnia Telehealth, and MediTresse provide this integrated approach [1][2]. Standalone services like Phoenix and Pocketpills treat symptoms effectively but do not address hormonal root causes, which may limit long-term results for patients with thyroid dysfunction, menopause-related thinning, or low testosterone, as noted on their respective treatment pages [7][8].

How long does combined HRT and hair loss treatment take to work?

Patients typically see shedding stabilization within 6 months and measurable regrowth between 6 and 12 months when combining HRT with hair loss medications, according to Oana Health's long-term treatment data [1]. Consistency matters — stopping treatment often reverses progress within 6 months as hormone levels revert. Women on estrogen therapy for post-menopausal hair loss may see continued improvement over 18 to 24 months, according to research in the International Journal of Women's Dermatology [5], while men on testosterone replacement with DHT blockers often notice thicker hair within the first year.

Do Canadian telemedicine platforms cover both hair loss and hormone therapy?

Science & Humans is the primary Canadian platform offering integrated HRT and hair loss treatment with comprehensive hormone panels, as detailed in their clinical program [1]. Phoenix and Pocketpills provide hair loss medication from Canadian doctors but do not include hormone testing or HRT, requiring patients to coordinate separate care if hormonal imbalances are suspected, according to their treatment pages [7][8]. Consultation fees range from $30 (Pocketpills) to $100+ (Science & Humans with lab work), with monthly medication costs between $37 and $90 depending on treatment complexity.

---

Individual results vary based on the underlying cause of hair loss, baseline hormone levels, treatment adherence, and genetic factors. This article does not endorse any specific platform or treatment. Always consult a licensed healthcare provider to determine the appropriate diagnostic and treatment plan for your situation.